MedTrace Logo

Validation of a Smartwatch in Persons With Multiple Sclerosis

NCT03750097 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 58

Last updated 2019-04-12

No results posted yet for this study

Summary

The study is designed to validate the accuracy of steps detected by a commercially available smartwatch in persons with multiple sclerosis. Specifically, the investigators examine whether a smartwatch can detect steps accurately during slow, comfortable and fast overground walking. The total steps counted by the smartwatch will be compared to those counted by an accelerometer commonly used in clinical studies and the actually walked steps.

Conditions

Interventions

BEHAVIORAL

Comfortable walking velocity (CWV)

Walking for 250 Steps with self-selected comfortable walking velocity while wearing the two accelerometers (Polar M600 and ActiGraph wGT3X-BT)

BEHAVIORAL

Slow walking velocity (SWV: CWV - 20%)

Walking for 250 Steps with slow walking velocity while wearing the two accelerometers (Polar M600 and ActiGraph wGT3X-BT). Slow walking consists of walking with 20% slower than the self-selected comfortable walking velocity by following a researcher who controls the walking velocity with a measuring wheel.

BEHAVIORAL

Fast walking velocity (FWV: CWV + 20%)

Walking for 250 Steps with fast walking velocity while wearing the two accelerometers (Polar M600 and ActiGraph wGT3X-BT). Fast walking consists of walking with 20% faster than the self-selected comfortable walking velocity by following a researcher who controls the walking velocity with a measuring wheel.

Sponsors & Collaborators

  • Neurological Rehabilitation Center Quellenhof

    collaborator UNKNOWN

  • ZTM Bad Kissingen

    collaborator OTHER

  • University of Erlangen-Nürnberg

    lead OTHER

Principal Investigators

  • Klaus Pfeifer, Prof. Dr. · Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Department of Sport Science and Sport

  • Peter Flachenecker, Prof. Dr. med. · Neurological Rehabilitation Center Quellenhof

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-01
Primary Completion
2018-12-15
Completion
2019-01-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03750097 on ClinicalTrials.gov